Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACC-001 and QS-21 in mild to moderate Alzheimer's disease
NCT00479557Phase 2Completed
- Sponsor
- Pfizer
- Start
- May 2007
- Primary completion
- Jan 2013
- Countries
- 3
01
Overview
A Phase 2 trial of vanutide cridificar in Alzheimer's disease (AD), sponsored by Pfizer. Started May 2007; status: completed.
02
Drugs
vanutide cridificar
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00479557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00479557.